GammaFlu‑COVID
SARS‑CoV‑2 infection
PreclinicalActive
Key Facts
About Gamma Vaccines
Australian biotech leveraging photon‑inactivated virus technology to create broad‑spectrum vaccines for flu, COVID‑19, and other viral threats.
View full company profileTherapeutic Areas
Other SARS‑CoV‑2 infection Drugs
| Drug | Company | Phase |
|---|---|---|
| COVID‑19 Saliva Antigen Test | Salignostics | Pre‑clinical |